MedPath

Sleep, Fatigue, and Dexamethosone in Children With Leukemia

Phase 3
Completed
Conditions
Leukemia
Interventions
Drug: Dexamethosone
Registration Number
NCT00075101
Lead Sponsor
National Institute of Nursing Research (NINR)
Brief Summary

The purpose of this study is to determine the relationship between dexamethosone (steroid) and children's sleep and fatigue.

Detailed Description

Approximately 134 children and adolescents will be enrolled. All children and adolescents will wear a wrist actigraph for two consecutive 5-day study periods. Children and adolescents will have blood drawn 2 times on Day 1 when they are on dexamethosone. Their parents will complete a sleep diary and fatigue questionnaire by telephone on Days 2 and 5 of both study periods.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
134
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Study CycleDexamethosone-
Primary Outcome Measures
NameTimeMethod
Fatigue and sleep quality changes10 days
Secondary Outcome Measures
NameTimeMethod
Pharmacogenetics with dextamethasone use5 days
Pharmacokinetics with dextamethasone use5 days

Trial Locations

Locations (1)

St. Jude Children Research Hospital

🇺🇸

Memphis, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath